Janux Therapeutics (JANX) had the highest return between January 26, 2024 and February 28, 2024 by a small-cap US stock, returning 376.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Janux Therapeutics (JANX) | 1/26/2024 - 2/28/2024 | 376.92% |
GeneDx (WGS) | 1/26/2024 - 2/28/2024 | 158.33% |
Intuitive Machines (LUNR) | 1/26/2024 - 2/28/2024 | 127.91% |
Iovance Biotherapeutics (IOVA) | 1/26/2024 - 2/28/2024 | 126.36% |
Ocular Therapeutix (OCUL) | 1/26/2024 - 2/28/2024 | 123.6% |
Trevi Therapeutics (TRVI) | 1/26/2024 - 2/28/2024 | 118.66% |
Gaotu Techedu Inc DRC (GOTU) | 1/26/2024 - 2/28/2024 | 116.43% |
Arcutis Biotherapeutics (ARQT) | 1/26/2024 - 2/28/2024 | 114.64% |
Nano X Imaging (NNOX) | 1/26/2024 - 2/28/2024 | 102.92% |
Sana Biotechnology (SANA) | 1/26/2024 - 2/28/2024 | 97.23% |
Jumia Technologies (JMIA) | 1/26/2024 - 2/28/2024 | 89.86% |
Taysha Gene Therapies (TSHA) | 1/26/2024 - 2/28/2024 | 79.59% |
BigBearai (BBAI) | 1/26/2024 - 2/28/2024 | 75.42% |
Gorilla Technology (GRRR) | 1/26/2024 - 2/28/2024 | 73.98% |
Beam Therapeutics (BEAM) | 1/26/2024 - 2/28/2024 | 72.85% |
Dogness International Corp Class A (DOGZ) | 1/26/2024 - 2/28/2024 | 72.63% |
Vera Therapeutics (VERA) | 1/26/2024 - 2/28/2024 | 69.52% |
Byrna Technologies (BYRN) | 1/26/2024 - 2/28/2024 | 69.44% |
Nyxoah (NYXH) | 1/26/2024 - 2/28/2024 | 69.12% |
Emergent Biosolutions (EBS) | 1/26/2024 - 2/28/2024 | 68.42% |
Gyre Therapeutics (GYRE) | 1/26/2024 - 2/28/2024 | 65.27% |
Quantum-Si (QSIAW) | 1/26/2024 - 2/28/2024 | 65% |
CytomX Therapeutics (CTMX) | 1/26/2024 - 2/28/2024 | 64.94% |
Cogent Biosciences (COGT) | 1/26/2024 - 2/28/2024 | 63.47% |
Stoke Therapeutics (STOK) | 1/26/2024 - 2/28/2024 | 63.11% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
